European Journal of Medicinal Chemistry (2020)
Update date:2022-08-17
Topics:
Erdmann, Frank
Günther, Stefan
Ghazy, Ehab
Hügle, Martin
Herp, Daniel
Jung, Manfred
Morales, Elizabeth R.
Robaa, Dina
Romier, Christophe
Schmidt, Matthias
Schmidtkunz, Karin
Sippl, Wolfgang
Zeyen, Patrik
Histone modifying proteins, specifically histone deacetylases (HDACs) and bromodomains, have emerged as novel promising targets for anticancer therapy. In the current work, based on available crystal structures and docking studies, we designed dual inhibitors of both HDAC6/8 and the bromodomain and PHD finger containing protein 1 (BRPF1). Biochemical and biophysical tests showed that compounds 23a,b and 37 are nanomolar inhibitors of both target proteins. Detailed structure-activity relationships were deduced for the synthesized inhibitors which were supported by extensive docking and molecular dynamics studies. Cellular testing in acute myeloid leukemia (AML) cells showed only a weak effect, most probably because of the poor permeability of the inhibitors. We also aimed to analyse the target engagement and the cellular activity of the novel inhibitors by determining the protein acetylation levels in cells by western blotting (tubulin vs histone acetylation), and by assessing their effects on various cancer cell lines.
View Morewebsite:http://www.hybio.com.cn
Contact:+86 755 26588093
Address:No.9 Linkong West Street, Hengdian Street, Huangpi District, Wuhan City, China.
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
Contact:+86-0512-69209969
Address:Room 317,Lushan Road,Suzhou New District,Jiangsu Province,China.
Lianyungang Yunbo Chemical Co.,Ltd.
Contact:518-81066110
Address:B907,Dongsheng"Mingdu Square,21-2 East Chaoyang Road,Xinpu,(sale department)
Contact:021-50278900
Address:No.6,Room 201 ,Lane 299,bisheng road ,shanghai ,china
Doi:10.1021/ol0526064
(2006)Doi:10.1016/0925-8388(91)90081-6
(1991)Doi:10.1007/BF01517081
(1880)Doi:10.1016/S0038-1098(97)00053-7
(1997)Doi:10.1016/0022-2860(82)80012-4
(1982)Doi:10.1016/0040-4039(96)00872-6
(1996)